GHRP-2 · Research brief

Bulk Tesamorelin: Pricing, Testing and MOQs Explained

Real Peptides Research TeamEditorial

Updated September 9, 202610 min read

60 WORDS

Short answer

Almost everything a lab pays for in bulk tesamorelin was decided before the powder ever touched a vial. Tesamorelin is a 44-amino-acid analogue of human growth hormone-releasing hormone (GHRH), carrying a trans-3-hexenoyl group on the N-terminal tyrosine. Forty-four residues means forty-four coupling cycles on the resin, and every cycle that runs below perfect efficiency reappears later as a deletion impurity…

Key takeaways

Bulk tesamorelin is research-grade tesamorelin acetate supplied as lyophilised powder in lot-numbered vials with a certificate of analysis, and it is not a drug product or authorised for human or animal use.
The 44-amino-acid chain length is the dominant cost driver: at 99% average coupling efficiency, theoretical full-length yield across 44 cycles is roughly 64%, dropping to about 41% at 98%.
MOQ tiers exist because lyophilisation, fill and finish, and per-lot analytics such as HPLC, mass spectrometry and Karl Fischer water content are fixed costs spread across vial count.
A purity percentage without a chromatogram is a marketing figure; the chromatogram reveals what the remaining fraction actually consists of.
Net peptide content, residual water and acetate counterion mean two vials with identical labels can hold different amounts of target peptide.
Lot-matched certificates that can be looked up by lot number are the fastest way to separate a genuine supplier from a reseller.
Independent third-party retesting on a first order, and again after any supplier change, costs far less than rebuilding a study on misidentified material.

That is why wholesale quotes at the same stated purity can differ so widely. Our team has reviewed enough incoming lots to see the pattern clearly: cheap material is rarely cheaper chemistry. It is usually fewer purification passes and thinner paperwork.

What is bulk tesamorelin?

Bulk tesamorelin is research-grade tesamorelin acetate supplied at volume as lyophilised powder in sealed, lot-numbered vials, priced in tiers against a minimum order quantity (MOQ) rather than per single unit. Every lot should carry a certificate of analysis (COA) reporting HPLC purity and mass-spectrometry identity. It is research-use-only material, not a drug product.

The number most buyers fixate on is purity percentage, and it is the least informative figure on the page. HPLC area percent tells you what fraction of UV-absorbing material eluted as the main peak under one method, not what the remaining fraction is, and it says nothing about how much of the vial mass is actually peptide. This piece covers what physically ships in a bulk tesamorelin order, what sets the price per milligram, and how to audit a supplier's documentation before committing to volume.

What actually ships when you order at volume

Bulk tesamorelin arrives as a white to off-white lyophilised cake in sealed, stoppered glass vials, boxed by lot, with research-use-only labelling and a lot-specific certificate of analysis. Vial formats and declared milligrams per vial vary between suppliers, which is the first place volume comparisons quietly break down.

Two label details deserve attention. The declared peptide mass, and whether that mass refers to gross vial fill or net peptide content. Lyophilised peptide salts carry residual water and a counterion, acetate in the case of tesamorelin acetate, and both occupy mass in the vial without being target peptide.

Storage of bulk tesamorelin is simpler than most buyers expect. Sealed and dry, lyophilised material tolerates the short ambient transit windows domestic shipping produces, then belongs in a freezer at -20°C or colder, protected from light and moisture. Once a lot is dissolved in the solvent a laboratory has validated for its own assay work, stability falls sharply, and aliquoting into single-use volumes avoids the repeated freeze-thaw cycles that fragment peptide chains.

What should not be in the box matters too. Research suppliers do not bundle solvents, syringes or consumables with a compound, because bundling implies an administration route no research-grade material is authorised for. This material is supplied for laboratory research only, never for human or animal administration, and anyone whose question is really about an animal's health should talk to their veterinarian rather than sourcing research chemicals. In our experience inspecting inbound shipments, the packaging reveals as much about a vendor's compliance posture as the COA does.

Why the price per milligram moves the way it does

The price of bulk tesamorelin is set at the synthesis bench, then adjusted by how many vials share the cost of testing. Solid-phase peptide synthesis builds the 44-residue chain one amino acid at a time. Run the arithmetic: at 99% average coupling efficiency, theoretical full-length yield across 44 cycles is 0.99 raised to the 44th power, roughly 64%. At 98% average efficiency it falls to about 41%. Everything lost becomes truncated and deletion sequences that preparative reverse-phase HPLC has to strip out, and every purification pass raises purity while destroying more yield.

The N-terminal trans-3-hexenoyl group adds a further acylation and clean-up step. That modification is the structural feature the literature credits with resisting dipeptidyl peptidase-4 (DPP-4) cleavage, and it is one reason bulk tesamorelin does not price like a simple five-residue research peptide.

Then there is fill and finish. Lyophilisation cycles, vials, stoppers, nitrogen overlay, inspection and labelling behave as fixed overhead: below a certain vial count that overhead dominates the quote, which is the genuine reason MOQ tiers exist. Lot analytics work identically. HPLC purity, mass-spectrometry identity, water content by Karl Fischer titration and bacterial endotoxin testing where cell work requires it are priced per lot, not per vial. Quotes for bulk tesamorelin therefore vary widely by lot size and supplier, and a per-milligram figure means nothing without the lot size it was quoted against.

Here is the comparison most buyers get wrong. They compare price per vial and ignore net peptide content. If one COA reports net peptide content and the competing COA reports only area percent purity, the two quotes are not describing the same quantity of peptide.

How to audit a supplier before committing

Auditing a bulk tesamorelin supplier comes down to one request: the lot-specific certificate of analysis with the raw chromatogram attached, not a summary retyped into a PDF. A summary states a figure. A chromatogram shows where the remaining fraction sits, how the baseline behaves, and whether a shoulder is hiding beside the main peak.

Four analytical outputs are worth insisting on before any volume commitment: HPLC purity with the method stated, molecular weight identity by ESI-MS or MALDI-TOF checked against the published sequence, water content, and net peptide content. Endotoxin data by LAL assay matters additionally for cell-based work. The lot number printed on the vial must match the certificate, and the certificate should be independently retrievable rather than emailed on request, which is why Real Peptides publishes lot records on its certificates of analysis page.

One clean lot proves nothing about the next. Batch-to-batch impurity drift is the quiet destroyer of longitudinal data, so small-batch synthesis with verified amino-acid sequencing and retained samples is worth more than a single impressive number. Sending a retain aliquot to an independent analytical laboratory on a first order, and again whenever a supplier changes, costs less than a study built on misidentified material.

Logistics is the last filter. Domestic stock with dispatch inside 24 hours of order shortens the temperature exposure window, and stocking sites are listed on the locations page. The same documentation standard runs across related growth hormone secretagogue research compounds such as GHRP-2 and the wider research peptide catalogue. Everything here is educational information about sourcing and laboratory handling, not guidance on use in people or animals.

Bulk Tesamorelin Suppliers: Documentation Compared

Not every bulk tesamorelin quote describes the same product, and the difference lives in the paperwork rather than the powder. This table maps the supplier types research buyers actually encounter against what each one can document.

Supplier type	Purity documentation typically offered	Identity confirmation	MOQ and pricing behaviour	Professional assessment
Offshore bulk broker reselling unnamed API	Generic certificate, often undated and not tied to the lot shipped	Rarely includes a mass spectrum; identity asserted rather than shown	Lowest headline price, large MOQ, long lead times and customs exposure	Cheapest per milligram and the hardest to verify; unusable when lot identity has to be documented
Dropship reseller with white-label vials	Synthesis-house certificate passed along without independent retest	Molecular weight data sometimes present but not linked to the shipped lot	Small MOQ, flexible terms, mid-range pricing	Workable for exploratory bench screening, weak when a study needs traceable lots across months
Research supplier with lot-matched COA and third-party testing	Lot-specific certificate with chromatogram, water content and peptide content reported	ESI-MS or MALDI-TOF molecular weight confirmation against the sequence	Tiered MOQ pricing, domestic stock, short dispatch windows	Best fit for reproducible research; verification cost is built into the price instead of deferred to the buyer
Pharmacopoeial API distributor	Full monograph documentation and regulatory dossiers	Complete identity, related substances and residual solvent profiling	Very high MOQ measured in grams or kilograms, heavy qualification paperwork	Built for drug manufacturing, not bench research; usually inaccessible and unnecessary for a single laboratory
Marketplace listing with no certificate	None, or a certificate image with the lot field left blank	No identity data of any kind	Unpredictable pricing, no lot continuity between orders	Not a sourcing option; unidentified material contaminates conclusions before the first assay runs

What If: Research Sourcing Scenarios

What if the certificate lot number does not match the vial label?

Quarantine the shipment and request the correct lot record before a single vial is opened. A mismatch means either a clerical error or paperwork belonging to a different synthesis run, and there is no way to tell which from the outside of a box. Unopened vials generally remain returnable; opened ones do not. Suppliers running real lot control resolve this within a day because the record exists, and suppliers who cannot produce it were never lot-controlled to begin with.

What if a bulk tesamorelin shipment sits in transit and arrives warm?

Record the arrival condition, photograph the packaging, and contact the supplier before the material goes into storage. Sealed lyophilised powder is considerably more tolerant of ambient excursions than a peptide already in solution, so a warm box is often not a write-off, but tolerance is not a guarantee and only that lot's stability data can speak to it. Partial degradation is invisible: neither appearance nor a bench-level check will detect it. Domestic stock and 24-hour dispatch exist largely to shrink this exposure window.

What if one bulk tesamorelin quote lands far below every other?

Ask how many purification passes the lot received and request the chromatogram before treating that quote as comparable. Steep discounts usually reflect fewer preparative HPLC passes, a larger crude batch carrying more related substances, or a purity figure quoted against gross vial mass rather than net peptide content. Occasionally the discount is genuine scale economics. The chromatogram settles the question in about a minute, and any supplier that cannot send one has already answered it.

What if a study needs identical material across several months?

Buy a single large lot up front, reserve retain samples, and record the lot number in the method section. Batch-to-batch variation in impurity profile is the quiet source of drift in longitudinal work, and no supplier can honestly promise that a later lot matches an earlier one unless both were synthesised under the same conditions. Ask directly whether inventory can be reserved from one lot number for the duration of the project.

The unglamorous truth about wholesale purity claims

Let's be direct about this: a purity percentage published on a product page is a claim, not data. Area percent measures what fraction of UV-absorbing material eluted as the main peak under one gradient, on one instrument, on one day. Change the method and the number moves. It says nothing about net peptide content, nothing about residual water, and nothing about which deletion sequences make up the remainder. The only version of that figure worth paying for is printed on a lot-specific certificate beside a chromatogram and a mass spectrum, for a lot you can name. Everything else is decoration on a bulk tesamorelin invoice.

Bulk tesamorelin buying rewards patience in a way few laboratory purchases do. The compound is a 44-residue chain, which means the distance between a good lot and a mediocre one is invisible in the vial and permanent in the data. Labs that ask for the chromatogram before the invoice tend to reorder the same lot number for years. Labs that shop on headline price per milligram tend to spend the following quarter working out why an assay stopped behaving. The paperwork is the product.

References

Peer-reviewed sources on Tesamorelin indexed in PubMed, listed for research context. Real Peptides supplies Tesamorelin for laboratory research use only.

Body composition, hepatic fat, metabolic, and safety outcomes of Tesamorelin, a GHRH analogue, in HIV-associated lipodystrophy: A meta-analysis of randomized controlled trials. Obesity research & clinical practice, 2026. PMID 41545261. doi:10.1016/j.orcp.2026.01.002
Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy. Drugs, 2011. PMID 21668043. doi:10.2165/11202240-000000000-00000
Effects of Tesamorelin on Neurocognitive Impairment in Persons With HIV and Abdominal Obesity. The Journal of infectious diseases, 2025. PMID 39813152. doi:10.1093/infdis/jiaf012
Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors. AIDS (London, England), 2024. PMID 38905488. doi:10.1097/QAD.0000000000003965
Effect of tesamorelin in people with HIV with and without dorsocervical fat: Post hoc analysis of phase III double-blind placebo-controlled trial. Journal of clinical and translational science, 2023. PMID 36845310. doi:10.1017/cts.2022.515
Tesamorelin improves fat quality independent of changes in fat quantity. AIDS (London, England), 2021. PMID 33756511. doi:10.1097/QAD.0000000000002897
Delineating tesamorelin response pathways in HIV-associated NAFLD using a targeted proteomic and transcriptomic approach. Scientific reports, 2021. PMID 34006921. doi:10.1038/s41598-021-89966-y
Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD. JCI insight, 2020. PMID 32701508. doi:10.1172/jci.insight.140134

Questions

Bulk tesamorelin is priced in tiers against a minimum order quantity rather than per single vial, because synthesis, purification, fill and finish, and per-lot analytical testing are largely fixed costs spread across vial count. The larger the lot, the smaller each vial's share of that overhead. Quotes vary widely by supplier and lot size, so a per-milligram figure only means something when the lot size it was quoted against is stated alongside it.

Bulk tesamorelin is sold as research-use-only material to researchers, laboratories and institutions, and legitimate suppliers require the buyer to accept research-use terms at checkout. It is not a drug product, is not supplied for human or veterinary administration, and is not intended for diagnostic use. Any vendor willing to discuss administration in people or animals is operating outside the research-use framework.

MOQs differ substantially between supplier types and are set by where fill-and-finish overhead stops dominating the quote. Research suppliers usually set MOQ in vial counts, while pharmacopoeial API distributors set it in grams or kilograms with extensive qualification paperwork attached. The practical approach is to ask for pricing at two or three vial counts and compare the per-milligram slope rather than the headline number.

The branded prescription formulation is a finished, regulated drug product manufactured under pharmaceutical controls with a defined excipient formulation, labelling and prescribing framework. Research-grade tesamorelin acetate is not a drug product and carries no such authorisation. It is supplied as lyophilised powder for laboratory research only, documented by a lot certificate of analysis rather than a drug approval file.

A useful certificate reports HPLC purity with the analytical method stated, molecular weight identity by ESI-MS or MALDI-TOF checked against the published 44-residue sequence, water content by Karl Fischer titration, and net peptide content. Bacterial endotoxin testing by LAL assay matters for cell-based work. The certificate must name the lot number printed on the vial, and the chromatogram should be attached rather than summarised.

Sealed lyophilised peptide is comparatively robust and tolerates the short ambient windows of domestic transit, but long-term storage belongs in a freezer at -20°C or colder, protected from light and moisture. Once dissolved in a solvent the laboratory has validated for its own work, stability drops sharply. Aliquoting into single-use volumes avoids repeated freeze-thaw cycles, which fragment peptide chains and shift the impurity profile.

The dominant risk is not toxicity, it is unusable data. Material with no lot-matched certificate may contain deletion sequences, truncated fragments, a different counterion load, or in the worst case a different peptide entirely, and none of that is visible in the vial. A large unverified lot also compounds the problem, because every experiment run against it inherits the same unknown. Third-party retesting on receipt is the cheapest insurance available.

Tesamorelin is a modified analogue of growth hormone-releasing hormone and acts at the GHRH receptor in the published literature. GHRP-2 and MK-677 are described as growth hormone secretagogues acting through the ghrelin receptor, GHS-R1a, which is a different receptor pathway entirely. They are also far shorter or non-peptidic molecules, which is why their cost per milligram sits nowhere near that of a 44-residue chain.

Because stepwise yield compounds. Solid-phase synthesis adds one residue at a time, and at 99% average coupling efficiency the theoretical full-length yield across 44 cycles is about 64%, falling to roughly 41% at 98%. The lost fraction becomes closely related impurities that preparative reverse-phase HPLC must remove, and each purification pass sacrifices further yield. The trans-3-hexenoyl modification on the N-terminal tyrosine adds another acylation and clean-up step.

Yes, and a supplier that hesitates has answered the more important question. Lot certificates should be retrievable independently rather than issued on request, which is why lot records are published on the certificates page. Ask specifically for the lot currently in stock, with the chromatogram attached, and confirm that the lot number on the certificate matches what will ship.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA